Indacaterol (arcapta neohaler) for chronic obstructive pulmonary disease

about

Indacaterol: a comprehensive review.

P2860

Q37057061-29784BC5-944E-4FB7-94C2-AF77CA0CB791

P2860

Indacaterol (arcapta neohaler) for chronic obstructive pulmonary disease

Item

http://www.wikidata.org/entity/Q35958673

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Indacaterol (arcapta neohaler) for chronic obstructive pulmonary disease

@ast

Indacaterol (arcapta neohaler) for chronic obstructive pulmonary disease

@en

type

Item

label

Indacaterol (arcapta neohaler) for chronic obstructive pulmonary disease

@ast

Indacaterol (arcapta neohaler) for chronic obstructive pulmonary disease

@en

prefLabel

Indacaterol (arcapta neohaler) for chronic obstructive pulmonary disease

@ast

Indacaterol (arcapta neohaler) for chronic obstructive pulmonary disease

@en

P1476

Indacaterol (arcapta neohaler) for chronic obstructive pulmonary disease

@en

P2093

Danielle L Cruthirds

http://www.w3.org/2001/XMLSchema#string

Rachel M Slaton

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of indacaterol 150 microg once-daily in COPD: a double-blind, randomised, 12-week study

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society

Cardiac safety of indacaterol in healthy subjects: a randomized, multidose, placebo- and positive-controlled, parallel-group thorough QT study.

Efficacy of a new once-daily long-acting inhaled beta2-agonist indacaterol versus twice-daily formoterol in COPD.

Onset of action of indacaterol in patients with COPD: comparison with salbutamol and salmeterol-fluticasone

Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium.

Bronchodilator effects of indacaterol and formoterol in patients with COPD.

Indacaterol, A Novel Once Daily Inhaled beta2-Adrenoreceptor Agonist.

Indacaterol: a new once daily long-acting beta(2) adrenoceptor agonist.

P304

86-98

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22605898

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

indacaterol maleate

P932

3351870

http://www.w3.org/2001/XMLSchema#string

Indacaterol (arcapta neohaler) for chronic obstructive pulmonary disease

about

P2860

P2860

Indacaterol (arcapta neohaler) for chronic obstructive pulmonary disease

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P921

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P921

P932